Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

PRP therapy effectively improves hair density and reduces hair loss in androgenetic alopecia.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Early hair loss may indicate future prostate issues.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.

Compound 15a was effective in inhibiting 5α-reductase.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

PRP with microneedling effectively treats hair loss, and dermoscopy helps evaluate results.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.